Managing opioid reduction in chronic pain: A qualitative study

  • Research type

    Research Study

  • Full title

    Reducing the use of opioids for chronic non-cancer pain: Patient and Health Professionals views

  • IRAS ID

    242720

  • Contact name

    Helen Poole

  • Contact email

    h.m.poole@ljmu.ac.uk

  • Sponsor organisation

    Liverpool John Moores University

  • Duration of Study in the UK

    0 years, 9 months, 0 days

  • Research summary

    Around one in five of the population worldwide experience chronic pain and its associated detrimental effects on the quality of their daily lives. A significant number of people with Chronic Non-Cancer Pain (CNCP) in the UK are on chronic regimens of high dose opioids with little benefit, but potential risks. There is a need to monitor and respond to the inappropriate use of prescription opioids and enhance health professional competencies and guidance for standards of care and best prescribing practice. Our ultimate aim is to develop an intervention to support health care professionals and patients during the process of reducing or discontinuing inappropriate opioid medication use for CNCP. To do this, our initial study will involve interviews with health care professionals involved in the care of patients with CNCP (e.g. Pain clinicians, specialist nurse prescribers, pharmacists) and patients about opioid use and discontinuation in the context of CNCP. Specifically, we will explore factors that influence decisions about opioid use, reduction and discontinuation; identify concerns, barriers and enablers to the process of reducing or discontinuing opioids; explore what support mechanisms participants would find helpful to facilitate behaviour change in this context from both practitioner and patient perspective. The results of the interviews will help us understand the support needed and will be used to devise the content and delivery of a brief intervention to support patients and health care professionals during the process of reducing or discontinuing inappropriate opioid use.

  • REC name

    North West - Greater Manchester South Research Ethics Committee

  • REC reference

    18/NW/0217

  • Date of REC Opinion

    17 Apr 2018

  • REC opinion

    Further Information Favourable Opinion